News
01-07-2011, 09:10 AM
Recruitment is underway for five specialists to join NICE's Diagnostics Advisory Committee as it considers the clinical and cost effectiveness of a DNA based biochip assay which examines breast cancer tumour markers. Randox Breast Cancer Array (BCA) uses a biochip to analyse 23 genes simultaneously in order to define the clinical sub-groups of breast tumours...
More... (http://mnt.to/f/3PLH)
More... (http://mnt.to/f/3PLH)